188 related articles for article (PubMed ID: 36028883)
1. Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis.
Moussa MD; Beyls C; Lamer A; Roksic S; Juthier F; Leroy G; Petitgand V; Rousse N; Decoene C; Dupré C; Caus T; Huette P; Guilbart M; Guinot PG; Besserve P; Mahjoub Y; Dupont H; Robin E; Meynier J; Vincentelli A; Abou-Arab O
Crit Care; 2022 Aug; 26(1):257. PubMed ID: 36028883
[TBL] [Abstract][Full Text] [Related]
2. Exposure to Arterial Hyperoxia During Extracorporeal Membrane Oxygenator Support and Mortality in Patients With Cardiogenic Shock.
Jentzer JC; Miller PE; Alviar C; Yalamuri S; Bohman JK; Tonna JE
Circ Heart Fail; 2023 Apr; 16(4):e010328. PubMed ID: 36871240
[TBL] [Abstract][Full Text] [Related]
3. Hyperoxia in patients with cardiogenic shock after myocardial infarction supported with venoarterial extracorporeal membrane oxygenation.
Ross P; Miller C; Sheldrake J; McGuiness W; Udy A; Burrell A
Aust Crit Care; 2021 Jan; 34(1):55-59. PubMed ID: 32620254
[TBL] [Abstract][Full Text] [Related]
4. ARTERIAL HYPEROXIA AND MORTALITY IN PATIENTS UNDERGOING VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION.
Celińska-Spodar M; Załęska-Kocięcka M; Banaś S; Kołsut P; Kowalik I; Kuśmierczyk M; Kuśmierski K; Litwiński P; Sitkowska-Rysiak E; Szymański J; Stępińska J
Shock; 2023 Jan; 59(1):20-27. PubMed ID: 36703274
[TBL] [Abstract][Full Text] [Related]
5. Oxygenation management during veno-arterial ECMO support for cardiogenic shock: a multicentric retrospective cohort study.
Winiszewski H; Vieille T; Guinot PG; Nesseler N; Le Berre M; Crognier L; Roche AC; Fellahi JL; D'Ostrevy N; Ltaief Z; Didier J; Arab OA; Meslin S; Scherrer V; Besch G; Monnier A; Piton G; Kimmoun A; Capellier G
Ann Intensive Care; 2024 Apr; 14(1):56. PubMed ID: 38597975
[TBL] [Abstract][Full Text] [Related]
6. VA-ECMO Support in Nonsurgical Patients With Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors.
Fux T; Holm M; Corbascio M; Lund LH; van der Linden J
Artif Organs; 2019 Feb; 43(2):132-141. PubMed ID: 30402887
[TBL] [Abstract][Full Text] [Related]
7. Venoarterial extracorporeal membrane oxygenation in immunocompromised patients with cardiogenic shock: a cohort study and propensity-weighted analysis.
Moyon Q; Triboulet F; Reuter J; Lebreton G; Dorget A; Para M; Chommeloux J; Stern J; Pineton de Chambrun M; Hékimian G; Luyt CE; Combes A; Sonneville R; Schmidt M
Intensive Care Med; 2024 Mar; 50(3):406-417. PubMed ID: 38436727
[TBL] [Abstract][Full Text] [Related]
8. Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors.
Winiszewski H; Piton G; Capellier G
Crit Care; 2022 Oct; 26(1):313. PubMed ID: 36253862
[No Abstract] [Full Text] [Related]
9. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry.
Weiner L; Mazzeffi MA; Hines EQ; Gordon D; Herr DL; Kim HK
Clin Toxicol (Phila); 2020 Jul; 58(7):705-710. PubMed ID: 31617764
[No Abstract] [Full Text] [Related]
10. Oxygen Thresholds and Mortality During Extracorporeal Life Support in Adult Patients.
Munshi L; Kiss A; Cypel M; Keshavjee S; Ferguson ND; Fan E
Crit Care Med; 2017 Dec; 45(12):1997-2005. PubMed ID: 28787294
[TBL] [Abstract][Full Text] [Related]
11. Outcomes following venoarterial extracorporeal membrane oxygenation in children with refractory cardiogenic disease.
Yang L; Ye L; Fan Y; He W; Zong Q; Zhao W; Lin R
Eur J Pediatr; 2019 Jun; 178(6):783-793. PubMed ID: 30834480
[TBL] [Abstract][Full Text] [Related]
12. Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock post-cardiac arrest.
Pineton de Chambrun M; Bréchot N; Lebreton G; Schmidt M; Hekimian G; Demondion P; Trouillet JL; Leprince P; Chastre J; Combes A; Luyt CE
Intensive Care Med; 2016 Dec; 42(12):1999-2007. PubMed ID: 27681706
[TBL] [Abstract][Full Text] [Related]
13. Protocol for a multicentre randomised controlled trial evaluating the effects of moderate hypothermia versus normothermia on mortality in patients with refractory cardiogenic shock rescued by venoarterial extracorporeal membrane oxygenation (VA-ECMO) (HYPO-ECMO study).
Jacquot A; Lepage X; Merckle L; Girerd N; Levy B
BMJ Open; 2019 Oct; 9(10):e031697. PubMed ID: 31615800
[TBL] [Abstract][Full Text] [Related]
14. Blood Lactate as a Reliable Marker for Mortality of Pediatric Refractory Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation.
Yang L; Fan Y; Lin R; He W
Pediatr Cardiol; 2019 Mar; 40(3):602-609. PubMed ID: 30600369
[TBL] [Abstract][Full Text] [Related]
15. Hyperoxia during extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest is associated with severe circulatory failure and increased mortality.
Bonnemain J; Rusca M; Ltaief Z; Roumy A; Tozzi P; Oddo M; Kirsch M; Liaudet L
BMC Cardiovasc Disord; 2021 Nov; 21(1):542. PubMed ID: 34775951
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Venoarterial Extracorporeal Membrane Oxygenation Plus Intra-Aortic Balloon Pumping for Treatment of Acute Myocardial Infarction Complicated by Cardiogenic Shock.
Nishi T; Ishii M; Tsujita K; Okamoto H; Koto S; Nakai M; Sumita Y; Iwanaga Y; Matoba S; Kobayashi Y; Hirata KI; Hikichi Y; Yokoi H; Ikari Y; Uemura S
J Am Heart Assoc; 2022 Apr; 11(7):e023713. PubMed ID: 35377180
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of in-hospital mortality in adult postcardiotomy cardiogenic shock patients successfully weaned from venoarterial extracorporeal membrane oxygenation.
Xie H; Yang F; Hou D; Wang X; Wang L; Wang H; Hou X
Perfusion; 2020 Jul; 35(5):417-426. PubMed ID: 31854226
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of oxygen challenge test for patients with cardiogenic shock receiving extracorporeal membrane oxygenation].
Dong L; Zhang X; Liang F; Yu X; Yang T; Li L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Dec; 29(12):1102-1106. PubMed ID: 29216944
[TBL] [Abstract][Full Text] [Related]
19. Hyperoxia Is Not Associated With 30-day Survival in Out-of-Hospital Cardiac Arrest Patients Who Undergo Extracorporeal Cardiopulmonary Resuscitation.
Kobayashi M; Kashiura M; Yasuda H; Sugiyama K; Hamabe Y; Moriya T
Front Med (Lausanne); 2022; 9():867602. PubMed ID: 35615086
[TBL] [Abstract][Full Text] [Related]
20. Risk prediction of in-hospital mortality in patients with venoarterial extracorporeal membrane oxygenation for cardiopulmonary support: The ECMO-ACCEPTS score.
Becher PM; Twerenbold R; Schrage B; Schmack B; Sinning CR; Fluschnik N; Schwarzl M; Waldeyer C; Seiffert M; Clemmensen P; Neumann JT; Bernhardt AM; Zeymer U; Thiele H; Reichenspurner H; Blankenberg S; Westermann D
J Crit Care; 2020 Apr; 56():100-105. PubMed ID: 31896442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
